Aptinyx Inc reported $73.95M in Current Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US USD 521.55M 10.97M
Biogen BIIB:US USD 9.77B 24.9M
Cara Therapeutics CARA:US USD 186.78M 10.61M
Daiichi Sankyo 4568:JP JPY 1.44T 19.68B
Halozyme Therapeutics HALO:US USD 653.2M 111.26M
Intra Cellular Therapies ITCI:US USD 759.76M 29.45M
IONIS PHARMACEUT IONS:US USD 2.15B 39.02M
Marinus Pharmaceuticals MRNS:US USD 177.01M 75.91M
Neurocrine Biosciences NBIX:US USD 1.21B 186.2M
Novartis NOVN:VX USD 36.95B 1.19B
Ultragenyx Pharmaceutical RARE:US USD 1.01B 334.13M
Vertex Pharmaceuticals VRTX:US USD 12.27B 767.5M